IMI impact on data - event | IHI Innovative Health Initiative

About this event

IMI has had ‘big data’ projects since its creation. What’s more, the projects are putting ‘big data’ principles into practice to advance research in the fields of cardiovascular disease, haematological malignancies (blood cancers), Alzheimer’s disease, and prostate cancer. IMI also boasts a number of projects working on health-related mobile and digital technologies.

This event was part of a series of live sessions that IMI is organising on IMI Impacts, where key actors explored the key challenges in their respective fields and demonstrate how IMI contributed. During these sessions, we also shared patients’ testimonies, as they are the ultimate beneficiaries of IMI’s funded research.

Furthermore, we engaged IMI stakeholders in a broader discussion on IMI’s impact. With this initiative, we demonstrated the successful IMI model of radical collaboration.

Agenda and presentations

Welcome and introduction

by Colm Carroll, Scientific Project Manager, IMI

What was the state of play before IMI # The challenge

by Dr Terttu Haring, Global Head for Clinical Digital Innovation, Sanofi Presentation Recording

How IMI projects have addressed the challenge & 'moved the needle' # Solutions from IMI projects
by

Dr Mats Sundgren, Director Health Informatics, AstraZeneca Presentation Recording

Dr Jennifer Lane, Versus Arthritis Clinical Research Fellow in Trauma and Orthopaedic Surgery, University of Oxford Presentation Recording

Prof. Dr. med. Lars Bullinger, Director of the Department of Haematology, Oncology and Tumourimmunology, Charité Universitätsmedizin Berlin Presentation Recording

Q&A Time Recording

Closing remarks

by Colm Carroll, Scientific Project Manager, IMI